Followed categories will be added to My News. Percheron has detailed why its Duchenne muscular dystrophy trial flopped – and why it needs to find a new drug candidate Imugene’s multiple ...
The rider of a purebred Shire mare who has been contesting Area Festivals – and aiming for the championships – said it is a pleasure to show what non-conventional dressage horses can do.
Avicursen is under clinical development by Percheron Therapeutics and currently in Phase II for Duchenne Muscular Dystrophy. According to GlobalData, Phase II drugs for Duchenne Muscular Dystrophy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results